Canadian Conference On
Lymphoproliferative Disorders

March 7-9, 2014 Whistler, British Columbia, Canada


Words of Welcome


On-line Viewing Index Access


6th Annual Canadian Conference on Lymphoproliferative Disorders (CCOLD)
Whistler, BC, March 7 – 9, 2014


On behalf of the planning committee, I have the pleasure of welcoming you to the 6th Annual Canadian Conference on Lymphoproliferative Disorders (CCOLD). 

We are very excited to have with us international experts in Lymphomas, Leukemia’s and Myeloma for our 2014 meeting. The scope of this meeting will highlight both recent research findings elucidating the pathophysiology of these diverse diseases, as well as changes in therapeutic advances that have had a large impact in the management of our patients. As in previous meetings the format will be didactic presentations as well as case based panel discussions.  

The focus of the 2014 conference is on Hodgkins and Follicular Lymphoma, Multiple Myeloma and Chronic Lymphocytic Leukemia.  Both lymphomas have had significant progress with respect to outcomes which will be reviewed.  We will discuss best management of high risk Myeloma and CLL, with a critical assessment of minimal residual disease in both diseases.

There will be opportunity for audience participation via keypad polling devices with the entire clinical faculty featured during the panel discussions. Internationally known researchers in Lymphoproliferative and Plasma Cell Disorders will provide keynote lectures and their perspectives on optimal management.


Confirmed Visiting Faculty


Dr. Ron Levy, Stanford, California
Dr. Ola Landgren, Bethesda, Maryland
Dr. Peter Borchmann, Cologne, Germany
Dr. Peter Johnson, Southhampton, UK
Dr. Nathan Fowler, Washington, DC
Dr. Paula Cramer, Cologne, Germany
Dr. William Wierda, Houston, Texas
Dr. Joseph M. Connors, Vancouver, BC

We will continue to support the “Young Investigators Research Awards Program” which has been very successful in providing educational and research support to trainees interested in Lymphoproliferative Disorders.  Posters outlining their research will be focused at a special reception Saturday afternoon. 

Please follow the link to download the abstract form right here!

The organizing committee for the Allied Health Special Interest Session have organized an exciting afternoon highlighting management of side effects from treatments experienced by our patients with LPD.  They will also present how best to communicate bad news. 


This event is an Accredited Group Learning Activity eligible for up to 12.5 Section 1 credits as defined by the Maintenance of Certification program of the Royal College of Physicians and Surgeons of Canada.  This program has been reviewed and approved by UBC Division of Continuing Professional Development. Each physician should claim only those credits he/she actually spent in the activity.


Yours truly,

Dr. Wendy Lam Wendy Lam, Burnaby, BC
On behalf of the Planning Committee


Planning Committee


Dr. Laurie Sehn, Vancouver, BC

Dr. Douglas Stewart, Calgary, AB

Dr. James Johnston, Winnipeg, MB

Dr. Michael Crump, Toronto, ON

Dr. Christine Chen, Toronto, ON

Dr. Chaim Shustik, Montreal, QC

Dr. Stephen Couban, Halifax, NS